English
Specials
Upgrade
Moneycontrol Be a PRO
Moneycontrol PRO
Get App Open
In App
Open App

You are Here : Moneycontrol Markets IPO Sudarshan Pharma Industries

IPO Issues Open Now

Sudarshan Pharma Industries

Sector Healthcare

Description Originally incorporated as ‘Sudarshan Specialty Chemsolve Private Limited’ in 2008 in Mumbai, their company was subsequently named ‘Sudarshan Pharma Industries Private Limited’. In 2016 the company was listed as a public limited company and became ‘Sudarshan Pharma Industries Limited’ (S.... More »

Address 301 3rd Floor Aura Biplex, SV Road Borivali(West) , Mumbai Maharashtra , India. Pincode : 400092

Issue Terms

Issue price / Floor Price (Rs) 71.00-73.00
Application per share (Rs) 73.00
Minimum investment amount (Rs) 116,800.00
Minimum bid (no of shares) 1600
Maximum Shares for Retail N.A.

Issue Date and Size

Issue opens 09-Mar-23
Issue closes 14-Mar-23
Listing on NSE SME
Issue size (Rs cr) 48.72 - 50.1
Mkt cap at issue price (Rs cr) N.A.

Lead Managers & Registrar

Lead Manager E-mail
GRETEX CORPORATE SERVICES LIMITED info@gretexgroup.com
Registrar KFIN TECHNOLOGIES PRIVATE LIMITED
E-mail einward.ris@kfintech.com

Shares on Offer

Shares on Offer Lakhs
Total shares offered N.A.
Of above, offered to public N.A.
Post-issue shares N.A.
Post-issue promoters' holding(%) N.A.

Company Financials (Rs cr)

Financials Crore
No of months N.A.
Turnover N.A.
Net profit / (loss) N.A.
Borrowings N.A.

News

Forum | Add a comment...

See More

Explore IPO's

IPO Calendar

Essential Info

Issues Open Now

Upcoming Issues

Specials

Tools

related searches for IPO's

View More

Sections
Desktop Version »
Follow us on
Facebook Twitter Instagram Teglegram Jio News
Available On
Download from Google Play Download from App Stoer Download from Windows Phone
ISO 27001 - BSI Assurance Mark
Disclaimer | Terms & Conditions | Privacy Policy | Cookie Policy | FAQs | Sitemap | Contact Us | Advertise with Us
Network 18 Sites: News18 | Firstpost | CNBC TV18 | In.com | Cricketnext | Overdrive | Topper Learning

Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.

Thank you for Voting

Why do you think so

Post